Nifty
Sensex
:
:
24050.60
77550.25
275.50 (1.16%)
918.60 (1.20%)

Hospital & Healthcare Services

Rating :
49/99

BSE: 540797 | NSE: SHALBY

153.89
10-Apr-2026
  • Open
  • High
  • Low
  • Previous Close
  •  153.47
  •  160
  •  152.36
  •  150.85
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  123558
  •  19119254.55
  •  274.7
  •  125.82

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 1,658.49
  • 205.84
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 2,126.20
  • N/A
  • 1.65

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 74.33%
  • 6.43%
  • 11.73%
  • FII
  • DII
  • Others
  • 4.47%
  • 0.00%
  • 3.04%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 14.11
  • 20.33
  • 10.53

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 9.26
  • 9.06
  • -0.50

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -16.46
  • -31.88
  • -54.88

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 35.48
  • 35.40
  • 40.35

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.13
  • 2.20
  • 2.48

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 14.44
  • 14.23
  • 15.63

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 25
Dec 24
Var%
Sep 25
Sep 24
Var%
Jun 25
Jun 24
Var%
Mar 25
Mar 24
Var%
Net Sales
272.13
275.63
-1.27%
285.43
267.54
6.69%
296.43
278.89
6.29%
264.89
244.23
8.46%
Expenses
241.87
241.73
0.06%
243.82
234.89
3.80%
254.89
233.68
9.08%
244.05
205.37
18.83%
EBITDA
30.25
33.91
-10.79%
41.61
32.65
27.44%
41.54
45.21
-8.12%
20.84
38.87
-46.39%
EBIDTM
11.12%
12.30%
14.58%
12.20%
14.01%
16.21%
7.87%
15.91%
Other Income
7.23
5.42
33.39%
4.47
7.16
-37.57%
7.01
9.70
-27.73%
5.32
4.99
6.61%
Interest
10.64
10.66
-0.19%
9.64
9.26
4.10%
9.37
8.12
15.39%
10.67
6.47
64.91%
Depreciation
17.61
16.32
7.90%
17.37
16.84
3.15%
16.52
16.37
0.92%
16.23
15.60
4.04%
PBT
9.23
12.35
-25.26%
19.07
13.70
39.20%
22.65
30.41
-25.52%
-0.74
21.78
-
Tax
7.95
15.34
-48.17%
11.80
11.34
4.06%
14.97
15.67
-4.47%
11.45
5.74
99.48%
PAT
1.28
-2.99
-
7.28
2.36
208.47%
7.68
14.74
-47.90%
-12.19
16.04
-
PATM
0.47%
-1.09%
2.55%
0.88%
2.59%
5.28%
-4.60%
6.57%
EPS
0.16
-0.17
-
0.78
0.32
143.75%
0.83
1.46
-43.15%
-1.02
1.55
-

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Net Sales
1,118.88
1,086.95
933.75
804.92
698.95
430.90
486.85
462.26
377.99
323.77
290.41
Net Sales Growth
4.93%
16.41%
16.01%
15.16%
62.21%
-11.49%
5.32%
22.29%
16.75%
11.49%
 
Cost Of Goods Sold
144.27
114.61
63.57
58.73
30.77
34.70
52.93
39.34
38.87
36.23
4.45
Gross Profit
974.61
972.35
870.18
746.19
668.18
396.20
433.92
422.91
339.12
287.54
285.95
GP Margin
87.11%
89.46%
93.19%
92.70%
95.60%
91.95%
89.13%
91.49%
89.72%
88.81%
98.46%
Total Expenditure
984.63
952.23
755.13
666.75
577.38
343.57
404.06
378.78
299.05
252.28
234.84
Power & Fuel Cost
-
22.45
19.70
16.25
14.49
12.31
12.98
12.66
9.43
7.59
6.79
% Of Sales
-
2.07%
2.11%
2.02%
2.07%
2.86%
2.67%
2.74%
2.49%
2.34%
2.34%
Employee Cost
-
184.58
155.44
143.64
114.74
56.96
65.50
64.60
45.08
38.90
28.92
% Of Sales
-
16.98%
16.65%
17.85%
16.42%
13.22%
13.45%
13.97%
11.93%
12.01%
9.96%
Manufacturing Exp.
-
525.49
444.54
382.26
368.79
217.63
240.98
239.99
180.67
149.77
177.68
% Of Sales
-
48.35%
47.61%
47.49%
52.76%
50.51%
49.50%
51.92%
47.80%
46.26%
61.18%
General & Admin Exp.
-
89.17
66.80
61.34
35.38
13.60
19.83
19.07
20.56
17.58
15.91
% Of Sales
-
8.20%
7.15%
7.62%
5.06%
3.16%
4.07%
4.13%
5.44%
5.43%
5.48%
Selling & Distn. Exp.
-
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
% Of Sales
-
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Miscellaneous Exp.
-
15.92
5.08
4.51
13.21
8.38
11.86
3.12
4.43
2.21
0.00
% Of Sales
-
1.46%
0.54%
0.56%
1.89%
1.94%
2.44%
0.67%
1.17%
0.68%
0.37%
EBITDA
134.24
134.72
178.62
138.17
121.57
87.33
82.79
83.48
78.94
71.49
55.57
EBITDA Margin
12.00%
12.39%
19.13%
17.17%
17.39%
20.27%
17.01%
18.06%
20.88%
22.08%
19.14%
Other Income
24.03
27.60
19.43
22.52
12.42
9.06
17.37
9.26
10.01
6.75
2.15
Interest
40.32
40.84
17.62
10.56
7.53
4.54
7.41
9.18
12.37
11.04
10.45
Depreciation
67.73
65.76
52.24
48.09
42.87
36.80
36.02
33.17
22.86
16.70
11.33
PBT
50.21
55.73
128.19
102.04
83.58
55.05
56.73
50.39
53.73
50.50
35.92
Tax
46.17
53.81
44.69
34.37
25.18
12.69
29.14
18.73
14.56
21.80
-0.40
Tax Rate
91.95%
96.55%
34.86%
33.68%
31.82%
23.05%
51.37%
37.17%
27.10%
43.17%
-1.11%
PAT
4.05
6.22
84.08
67.70
54.12
42.40
27.59
31.66
39.38
29.69
37.58
PAT before Minority Interest
8.06
1.92
83.50
67.68
53.97
42.36
27.59
31.65
39.17
28.70
36.32
Minority Interest
4.01
4.30
0.58
0.02
0.15
0.04
0.00
0.01
0.21
0.99
1.26
PAT Margin
0.36%
0.57%
9.00%
8.41%
7.74%
9.84%
5.67%
6.85%
10.42%
9.17%
12.94%
PAT Growth
-86.57%
-92.60%
24.19%
25.09%
27.64%
53.68%
-12.86%
-19.60%
32.64%
-21.00%
 
EPS
0.38
0.58
7.79
6.27
5.01
3.93
2.55
2.93
3.65
2.75
3.48

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Shareholder's Funds
992.19
1,000.37
927.69
876.33
834.66
799.16
779.79
751.46
251.41
205.02
Share Capital
107.49
107.41
107.31
108.01
108.01
108.00
108.01
108.01
87.41
87.89
Total Reserves
883.56
892.14
819.56
768.32
726.65
691.16
671.78
643.45
163.72
117.14
Non-Current Liabilities
289.53
387.83
269.47
233.60
150.04
144.41
130.13
140.01
290.88
206.82
Secured Loans
136.67
175.84
67.42
87.39
35.50
48.67
56.91
75.44
235.45
151.12
Unsecured Loans
0.00
0.13
0.00
0.00
0.00
0.00
0.00
0.00
49.95
49.95
Long Term Provisions
42.53
115.57
112.70
91.54
71.96
61.90
62.77
57.58
1.52
0.90
Current Liabilities
455.32
323.26
194.38
172.46
81.75
83.26
88.41
138.47
199.32
91.70
Trade Payables
118.42
129.57
87.92
70.73
57.60
60.16
56.27
49.17
39.23
46.78
Other Current Liabilities
92.68
86.51
55.91
57.14
23.58
22.37
31.48
48.78
63.26
35.43
Short Term Borrowings
240.66
103.96
49.10
43.49
0.00
0.00
0.00
15.72
26.07
9.32
Short Term Provisions
3.57
3.22
1.45
1.09
0.57
0.73
0.65
24.80
70.77
0.17
Total Liabilities
1,740.18
1,718.87
1,391.47
1,282.25
1,066.47
1,026.88
998.38
1,030.00
740.99
503.91
Net Block
955.40
966.21
685.17
675.40
659.56
672.48
691.88
650.32
323.01
319.28
Gross Block
1,328.71
1,285.02
909.84
860.19
804.16
782.09
766.12
691.50
340.55
427.87
Accumulated Depreciation
373.31
318.81
224.67
184.79
144.60
109.61
74.25
41.17
17.54
108.59
Non Current Assets
1,082.22
1,166.64
874.22
833.38
795.34
793.15
801.08
794.26
582.34
439.76
Capital Work in Progress
21.97
15.38
10.54
5.77
7.52
6.39
3.35
46.78
220.93
82.19
Non Current Investment
0.00
0.00
0.00
0.00
0.11
0.11
0.11
0.11
0.11
0.11
Long Term Loans & Adv.
91.38
180.02
175.95
148.21
120.55
110.80
102.02
96.76
38.01
37.99
Other Non Current Assets
13.48
5.03
2.56
4.01
7.61
3.37
3.72
0.28
0.27
0.18
Current Assets
657.96
552.25
517.25
442.26
271.12
233.73
197.29
235.73
158.65
64.16
Current Investments
94.63
80.64
145.72
24.70
15.52
27.88
10.78
0.00
0.00
0.00
Inventories
319.21
235.20
185.41
121.12
23.05
15.22
12.81
12.05
7.65
7.49
Sundry Debtors
175.21
144.63
106.37
100.99
94.69
94.86
81.36
50.88
33.63
31.43
Cash & Bank
34.86
27.22
12.29
110.56
83.59
28.73
25.40
115.90
15.85
16.07
Other Current Assets
34.04
9.30
5.46
14.55
54.27
67.04
66.95
56.90
101.52
9.17
Short Term Loans & Adv.
26.07
55.25
62.02
70.34
36.68
51.87
54.51
40.64
89.68
8.37
Net Current Assets
202.64
228.99
322.87
269.81
189.37
150.47
108.89
97.26
-40.67
-27.54
Total Assets
1,740.18
1,718.89
1,391.47
1,275.64
1,066.46
1,026.88
998.37
1,029.99
740.99
503.92

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Cash From Operating Activity
-4.34
19.60
67.78
18.92
79.15
55.37
43.40
13.94
60.45
4.57
PBT
55.73
128.19
102.04
79.15
55.05
56.73
50.39
53.73
50.50
35.92
Adjustment
84.75
51.75
39.94
53.48
37.57
36.86
35.73
33.46
26.11
16.86
Changes in Working Capital
-130.58
-140.28
-45.80
-90.73
-4.38
-18.06
-33.32
-60.72
-5.56
-38.09
Cash after chg. in Working capital
9.89
39.66
96.18
41.90
88.25
75.53
52.79
26.47
71.04
14.70
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-14.24
-20.06
-28.40
-22.98
-9.10
-20.16
-9.39
-12.54
-10.60
-10.13
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-35.64
38.07
-61.08
-60.30
-51.27
-30.67
1.39
-236.51
-153.30
-98.02
Net Fixed Assets
-19.99
-28.61
-15.88
-1.60
-24.61
-19.01
-31.19
-184.90
-59.84
-141.19
Net Investments
-87.50
-198.68
-250.70
-29.98
10.64
-18.73
-13.99
-0.19
-0.44
16.71
Others
71.85
265.36
205.50
-28.72
-37.30
7.07
46.57
-51.42
-93.02
26.46
Cash from Financing Activity
47.58
-150.69
-50.01
90.46
-29.86
-21.50
-51.25
222.22
95.64
74.91
Net Cash Inflow / Outflow
7.61
-93.03
-43.31
49.07
-1.98
3.21
-6.45
-0.36
2.78
-18.55
Opening Cash & Equivalents
27.18
12.24
55.55
6.48
8.46
5.26
11.71
11.70
8.91
27.46
Closing Cash & Equivalent
34.78
27.18
12.24
55.55
6.48
8.46
5.26
11.71
11.70
8.91

Financial Ratios

Consolidated /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Book Value (Rs.)
92.20
93.06
86.37
81.13
77.28
74.00
72.20
69.57
28.73
23.41
ROA
0.11%
5.37%
5.06%
4.60%
4.05%
2.72%
3.12%
4.42%
4.61%
8.49%
ROE
0.19%
8.67%
7.51%
6.31%
5.19%
3.49%
4.13%
7.81%
12.60%
19.50%
ROCE
7.07%
12.23%
10.72%
9.08%
6.85%
7.49%
6.94%
9.15%
12.21%
13.34%
Fixed Asset Turnover
0.83
0.85
0.91
0.84
0.54
0.63
0.63
0.73
0.84
0.80
Receivable days
53.70
49.06
47.01
51.09
80.28
66.06
52.21
40.80
36.67
33.29
Inventory Days
93.09
82.21
69.50
37.64
16.21
10.51
9.82
9.51
8.53
8.37
Payable days
394.90
624.41
492.96
761.23
619.39
52.03
49.27
54.08
62.80
86.10
Cash Conversion Cycle
-248.11
-493.14
-376.45
-672.49
-522.90
24.53
12.76
-3.77
-17.59
-44.44
Total Debt/Equity
0.43
0.31
0.15
0.18
0.05
0.08
0.09
0.15
1.31
1.09
Interest Cover
2.36
8.28
10.66
11.51
13.13
8.66
6.49
5.34
5.58
4.44

Top Investors:

News Update:


  • Shalby inaugurates oncology department along with radiotherapy facilities in Ahmedabad
    23rd Mar 2026, 11:52 AM

    With the launch of these advanced services, the hospital is now equipped to provide integrated cancer care

    Read More
  • Shalby inaugurates oncology department with advanced radiotherapy facilities in Surat
    9th Mar 2026, 16:44 PM

    With the launch of these advanced services, the hospital is now equipped to provide integrated cancer care

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.